SSMMX
Price
$14.99
Change
-$0.02 (-0.13%)
Updated
Jun 5 closing price
Net Assets
2.39B
VWLTX
Price
$10.87
Change
-$0.01 (-0.09%)
Updated
Jun 5 closing price
Net Assets
19.1B
Interact to see
Advertisement

SSMMX vs VWLTX

Header iconSSMMX vs VWLTX Comparison
Open Charts SSMMX vs VWLTXBanner chart's image
SSMMX vs VWLTX Comparison Chart in %
View a ticker or compare two or three
VS
SSMMX vs. VWLTX commentary
Jun 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSMMX is a Hold and VWLTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VWLTX has more cash in the bank: 19.1B vs. SSMMX (2.39B). VWLTX (3.70) and SSMMX (3.68) have matching dividends . SSMMX was incepted earlier than VWLTX: SSMMX (8 years) vs VWLTX (49 years). SSMMX (0.52) is less costly to investors than VWLTX (0.17). VWLTX is a more actively managed with annual turnover of: 35.00 vs. SSMMX (6.00). VWLTX has a lower initial minimum investment than SSMMX: VWLTX (3000) vs SSMMX (1000000). SSMMX annual gain was more profitable for investors over the last year : 7.83 vs. VWLTX (4.02). SSMMX return over 5 years is better than : 5.06 vs. VWLTX (-11.26).
SSMMXVWLTXSSMMX / VWLTX
Total Expense Ratio0.510.17300%
Annual Report Gross Expense Ratio0.520.17306%
Fund Existence8 years49 years-
Gain YTD2.0400.277737%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.39B19.1B12%
Annual Yield % from dividends3.683.70100%
Returns for 1 year7.834.02195%
Returns for 3 years12.331.49825%
Returns for 5 years5.06-11.26-45%
Returns for 10 yearsN/A-8.97-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AYTU2.250.13
+5.89%
Aytu BioPharma
CP89.930.43
+0.48%
Canadian Pacific Kansas City Limited
SCL51.28-0.27
-0.52%
Stepan Co
MDA38.33-2.76
-6.72%
MDA Space Ltd
AVXL2.57-0.25
-8.87%
Anavex Life Sciences Corp